Celanese (NYSE:CE) Stock Price Target Raised at Citigroup

Celanese (NYSE:CE) had its target price lifted by equities researchers at Citigroup from $58.00 to $65.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the basic materials company’s stock. Citigroup‘s target price indicates a potential upside of 30.74% from the company’s current price.

Other analysts have also issued reports about the stock. Mizuho set a $50.00 target price on shares of Celanese in a research note on Wednesday, August 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Celanese in a research note on Friday, August 21st. JPMorgan Chase & Co. lifted their price objective on shares of Celanese from $76.00 to $77.00 and gave the company an “overweight” rating in a report on Wednesday. KeyCorp initiated coverage on shares of Celanese in a research report on Thursday, September 10th. They issued an “overweight” rating and a $57.00 price objective for the company. Finally, Morgan Stanley dropped their target price on shares of Celanese from $72.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 16th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $61.88.

Celanese Trading Down 1.3%

CE traded down $0.64 during trading hours on Wednesday, reaching $49.72. 2,049,664 shares of the company’s stock traded hands, compared to its average volume of 2,073,868. The firm has a 50-day moving average price of $46.17 and a 200 day moving average price of $51.42. Celanese has a 52-week low of $35.13 and a 52-week high of $70.70. The company has a quick ratio of 0.87, a current ratio of 1.45 and a debt-to-equity ratio of 2.33. The firm has a market capitalization of $5.46 billion, a PE ratio of 20.98, a PEG ratio of 0.34 and a beta of 0.72.

Celanese (NYSE:CE) last released its earnings results on Monday, November 2nd. The basic materials company reported $1.65 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.09. Celanese had a return on equity of 13.72% and a net margin of 2.66%. The business had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the firm posted $1.34 earnings per share. The business’s revenue was up 5.7% compared to the same quarter last year. As a group, sell-side analysts predict that Celanese will post 6.00 EPS for the current fiscal year.

Insider Activity

In other news, SVP Mark Murray purchased 2,153 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were acquired at an average price of $45.52 per share, with a total value of $98,004.56. Following the transaction, the senior vice president owned 30,432 shares of the company’s stock, valued at $1,385,264.64. This represents a 7.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.34% of the company’s stock.

Institutional Trading of Celanese

A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new position in Celanese during the 2nd quarter worth about $614,675,000. Bank of America Corp DE bought a new stake in shares of Celanese in the 2nd quarter valued at about $62,580,000. Dimensional Fund Advisors LP lifted its position in shares of Celanese by 83.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,187,235 shares of the basic materials company’s stock worth $143,849,000 after purchasing an additional 993,193 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Celanese in the 2nd quarter worth approximately $44,564,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Celanese during the second quarter valued at approximately $31,261,000. 98.87% of the stock is owned by hedge funds and other institutional investors.

Celanese News Roundup

Here are the key news stories impacting Celanese this week:

• Positive Sentiment: Celanese reported Q3 adjusted EPS of $1.65, above the $1.56 consensus, and raised its FY2026 adjusted EPS outlook to $6.00–$6.25 from a consensus of $6.00. Celanese Q3 earnings beat estimates
• Positive Sentiment: Management is targeting $700 million–$800 million in 2027 free cash flow, with cost reductions and lower interest expense expected to help. Delivery against this target could support the company’s financial position. Celanese 2027 free cash flow target
• Positive Sentiment: JPMorgan raised its price target to $77 and maintained an Overweight rating; Barclays raised its target to $57 while keeping an Equal Weight rating. The higher targets provide a more favorable analyst outlook, though Barclays’ rating remains cautious.
• Neutral Sentiment: Celanese and Röchling are working to expand lower-carbon POM applications using captured CO?. The partnership could support sustainable product development, but its near-term financial impact is unclear. Celanese and Röchling partnership
• Negative Sentiment: Q3 revenue of $2.56 billion fell short of the $2.62 billion consensus. The sales miss, alongside questions about converting improved guidance into cash flow, may be tempering the positive earnings and outlook news.

Celanese Company Profile

Celanese Corporation (NYSE: CE) is a global chemical and specialty materials company headquartered in Irving, Texas. The company develops and manufactures engineered materials and chemical products used by manufacturers in industries including automotive, consumer goods, medical and healthcare, electronics, industrial equipment, energy and infrastructure.

Celanese operates primarily through its Engineered Materials and Acetyl Chain businesses. Its portfolio includes engineered polymers, thermoplastic compounds and other specialty materials, as well as acetyl products such as acetic acid, vinyl acetate monomer, emulsions and related intermediates.